121 – 130 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
Rydén, Lisa LU
; Fernö, Mårten
LU
; Stal, O
; Linderholm, B.
; Ostman, A
and Jirström, Karin
LU
(2009)
31st Annual San Antonio Breast Cancer Symposium
In Cancer Research
69(2).
p.132-132
- Contribution to journal › Published meeting abstract
-
Mark
Significantly higher expression of vascular endothelial growth factor (VEGF) and shorter survival after recurrences in premenopausal node negative patients with triple negative breast cancer
- Contribution to journal › Published meeting abstract
-
Mark
Cyclin B1 Is an Independent Prognostic Proliferation Marker with a High Reproducibility in a Population-Based Lymph Node Negative Breast Cancer Cohort
- Contribution to journal › Published meeting abstract
-
Mark
Is the prognostic value of Ki-67 dependent on ER status and histological grade?
- Contribution to journal › Published meeting abstract
-
Mark
Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer - A national survey performed at pathology departments in Sweden.
Rydén, Lisa LU
; Haglund, Monica
; Bendahl, Pär-Ola
LU
; Hatschek, Thomas
; Kolaric, Aleksandra
; Kovacs, Aniko
; Olsson, Ann
; Olsson, Hans
; Forsare, Carina
LU
and Fernö, Mårten
LU
(2009)
In Acta oncologica (Stockholm, Sweden)
48.
p.860-866
- Contribution to journal › Article
-
Mark
Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
Alkner, Sara LU ; Bendahl, Pär-Ola LU ; Fernö, Mårten LU ; Nordenskjöld, Bo and Rydén, Lisa LU
(2009)
In European Journal of Cancer
45.
p.2496-2502
- Contribution to journal › Article
-
Mark
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
Jögi, Annika LU ; Brennan, Donal J ; Rydén, Lisa LU
; Magnusson, Kristina
; Fernö, Mårten
LU
; Stål, Olle
; Borgquist, Signe
LU
; Uhlen, Mathias
; Landberg, Göran
LU
and Påhlman, Sven
LU
, et al.
(2009)
In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
22.
p.1564-1574
- Contribution to journal › Article
- 2008
-
Mark
Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast conservation surgery with or without postoperative radiotherapy
Niméus, Emma LU ; Krogh, Morten LU ; Malmström, Per LU ; Forsare, Carina LU
; Fredriksson, I
; Karlsson, P
; Nordenskjöld, B
; Stål, O
; Östberg, G
and Peterson, Carsten
LU
, et al.
(2008)
In Breast Cancer Research
10(2).
- Contribution to journal › Article
-
Mark
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
Honeth, Gabriella LU ; Bendahl, Pär-Ola LU ; Ringnér, Markus LU
; Saal, Lao
LU
; Gruvberger, Sofia
LU
; Lövgren, Kristina
LU
; Grabau, Dorthe
LU
; Fernö, Mårten
LU
; Borg, Åke
LU
and Hegardt, Cecilia
LU
(2008)
In Breast Cancer Research
10(3).
- Contribution to journal › Article
-
Mark
Tissue microarray based analysis of prognostic markers in invasive bladder cancer: Much effort to no avail?
- Contribution to journal › Article